Rituximab as Rescue Therapy for Atezolizumab-Induced IgA Vasculitis. (PubMed, Kidney Med) - Oct 6, 2026 - "This case highlights IgA vasculitis as a rare but serious renal complication of programmed death-ligand 1 inhibition and supports RTX as a potential rescue therapy in corticosteroid-refractory cases. Careful biomarker monitoring and multidisciplinary management are essential to balance renal protection with oncologic outcomes."
IO biomarker • Journal • Acute Kidney Injury • Chronic Kidney Disease • Genito-urinary Cancer • Genitourinary Neuroendocrine Carcinoma • Glomerulonephritis • Lupus Nephritis • Nephrology • Neuroendocrine Carcinoma • Oncology • Prostate Cancer • Renal Disease • Solid Tumor • Vasculitis • IL18 • IL2 • PD-L1 • TNFA
|
|
Cristina R Ortiz; Jose Arriola-Montenegro; Sandra M Herrmann; Sanjeev Sethi
|